Health
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
After emergency use of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was authorized, the observer-blinded, pivotal Coronavirus Efficacy (COVE) trial was amended on December 23, 2020, to include an open-label phase in…
-
Noosa News7 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General13 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News15 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family
-
General9 hours agoMan dies at shopping centre car park at Charlestown following reports of assault